Intel vs Pfizer: Founders, CEOs and History
Intel was founded in 1968 by Robert Noyce, Gordon Moore and is led by Lip-Bu Tan. Pfizer was founded in 1849 by Charles Pfizer, Charles Erhart and is led by Albert Bourla.
Company facts
Founders
Intel
Robert Noyce
Intel possesses the most well-known founding story in the entire history of Silicon Valley, famously founded by the effective, rebellious engineers who essentially invented the fundamental architecture of the modern digital world.
Gordon Moore
Gordon Moore co-founded Intel and served as a key technical leader, CEO, and chairman during the company's formative decades. His most important contribution was turning transistor scaling into a corporate operating philosophy.
Pfizer
Charles Pfizer
Pfizer possesses a historic, immigrant founding story, rooted entirely in the rapid industrial expansion of 19th-century Brooklyn and defined by an effective, intensely meticulous German chemist and his ambitious confectioner cousin.
Charles Erhart
Charles Erhart's role in Pfizer's founding is less celebrated than his cousin's, partly because the company carries Charles Pfizer's name and partly because his commercial contributions were less visible than the scientific achievements that drove the company'…
CEOs and their tenures
Intel
- Andy Grove1987–1998
CEO
Grove turned Intel into the dominant PC processor supplier; revenue grew from about $1.9B in 1987 to over $26B in 1998. His book 'Only the Paranoid Survive' became a management classic.
Source - Pat Gelsinger2021–2024
CEO
Gelsinger rebuilt Intel's process roadmap toward 18A, but capital spending outpaced revenue. After a $18.8B net loss in 2024 and a dividend suspension, the board pushed him out in December 2024.
Source - Lip-Bu Tan2025–present
Chief Executive Officer
Tan reframed Intel around customer commitments and cost discipline rather than building capacity ahead of demand. By Q2 2026 Intel had beaten guidance for several straight quarters and posted its fastest revenue growth in more than 15 years.
Source
Pfizer
- Ian Read2010–2018
Chief Executive Officer
He ruthlessly cut R&D spending and eliminated tens of thousands of jobs, significantly boosting short-term earnings per share despite massive patent cliffs for blockbuster drugs like Lipitor.
Source - Albert Bourla2019–present
Chairman and Chief Executive Officer
A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
Source - Dave Denton2022–2026
Chief Financial Officer
As CFO, he aggressively restructured the balance sheet following the Seagen acquisition, prioritizing debt reduction while defending the dividend.
Source - Chris Boshoff2025–present
Chief Scientific Officer and President, Research & Development
He completely restructured the research and development organization to focus on antibody-drug conjugates (ADCs), aggressively expanding Pfizer's pipeline of cancer therapeutics.
Source - Cecile Guegan2026–present
Interim Chief Financial Officer
She modernized the company's internal auditing and compliance structures, ensuring rapid but safe clinical execution for high-priority vaccine programs.
Source
Timeline: Intel and Pfizer side by side
1849Pfizer
Pfizer Founded
Charles Pfizer and Charles Erhart founded the company in Brooklyn.
1944Pfizer
Penicillin Scale-Up
Pfizer helped industrialize penicillin production during World War II.
1968Intel
Intel Founded
Robert Noyce and Gordon Moore founded Intel.
1971Intel
4004 Microprocessor
Intel introduced the 4004, one of the first commercial microprocessors.
1985Intel
386 Processor
Intel strengthened the x86 franchise that later dominated PCs.
1993Intel
Pentium Processor Launched
Intel introduced the Pentium processor in 1993.
1998Pfizer
Viagra Approved
The FDA approved Viagra in 1998.
2000Pfizer
Warner-Lambert Deal
Pfizer acquired Warner-Lambert, adding Lipitor.
2006Intel
Core Architecture
Intel revived product leadership with the Core architecture.
2019Pfizer
Albert Bourla becomes CEO
Albert Bourla became CEO of Pfizer in 2019. A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
2020Pfizer
BioNTech COVID Vaccine Partnership
Pfizer and BioNTech brought Comirnaty through emergency authorization.
2021Intel
IDM 2.0 Announced
Intel announced a strategy to expand manufacturing and foundry capabilities.
2021Intel
Pat Gelsinger Becomes CEO
Pat Gelsinger became Intel chief executive in February 2021.
2023Pfizer
Seagen Acquisition
Pfizer completed the $43 billion Seagen acquisition.
2025Intel
Lip-Bu Tan Becomes CEO
Lip-Bu Tan became CEO and reset the turnaround agenda around execution, cost, and focus.
2025Intel
$52.853B Revenue
Intel reported $52.853B in revenue and a $267M net loss attributable to Intel.
2025Intel
U.S. Government Takes 9.9% Stake
The U.S. government bought 433.3 million Intel shares at $20.47 for $8.9 billion, becoming the largest shareholder.
2025Intel
Nvidia Invests $5 Billion
Nvidia agreed to invest $5 billion in Intel and co-develop x86 PC and data-center products.
2025Intel
Altera Majority Sold
Intel closed the sale of 51% of Altera to Silver Lake on September 12, 2025.
2025Pfizer
Chris Boshoff Becomes CSO
Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.
2025Pfizer
Metsera Acquisition
Pfizer completed its acquisition of obesity drug developer Metsera in November 2025 for up to about $10 billion including CVRs.
2025Pfizer
FY2025 Revenue Base
Pfizer reported $62.579 billion of FY2025 revenue.
2026Intel
Q2 Revenue Up 25%
Intel reported $16.1 billion in Q2 2026 revenue, its fastest growth in more than 15 years.
2026Pfizer
Innovent Oncology Collaboration
Pfizer signed a 12-program cancer collaboration with Innovent Biologics: $650 million upfront and up to $9.85 billion in milestones.
Acquisitions
Intel
- Moovit2020$900M
- Habana Labs2019$2B
- Mobileye2017$15.3B
- Altera2015$16.7B
- McAfee2011$7.7B
Pfizer
- Metsera, Inc.2025$7B
- Seagen Inc.2023$43B
- Medivation Inc.2016$14B
- Wyeth2009$68B
- Pharmacia Corporation2003$60B
- Warner-Lambert Company2000$111B
Questions about Intel vs Pfizer
Who is the CEO of Intel Corporation and Pfizer Inc.?
Intel Corporation is led by Lip-Bu Tan and Pfizer Inc. is led by Albert Bourla. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Intel Corporation founded vs Pfizer Inc.?
Pfizer Inc. was founded in 1849 — 119 years before Intel Corporation, which was founded in 1968. Pfizer Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Intel Corporation.
How many employees does Intel Corporation have compared to Pfizer Inc.?
Intel Corporation employs approximately 85,100 people, while Pfizer Inc. employs approximately 75,000. Intel Corporation has the larger workforce at 85,100 employees, compared to Pfizer Inc.'s 75,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Intel Corporation and Pfizer Inc. headquartered?
Both Intel Corporation and Pfizer Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Intel Corporation and Pfizer Inc.?
Intel Corporation was founded by Robert Noyce, Gordon Moore. Pfizer Inc. was founded by Charles Pfizer, Charles Erhart.
Which company has a longer operating history — Intel Corporation or Pfizer Inc.?
Pfizer Inc. has been operating for approximately 177 years, making it the more established of the two companies. Intel Corporation has been in operation for around 58 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Intel vs Pfizer overview